Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
1,291,721
-
Shares change
-
+82,832
-
Total reported value, excl. options
-
$81,080,858
-
Value change
-
+$5,184,618
-
Number of buys
-
28
-
Number of sells
-
-35
-
Price
-
$62.77
Significant Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2023
113 filings reported holding PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY as of Q1 2023.
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,291,721 shares
.
Largest 10 shareholders include MORGAN STANLEY (263,047 shares), Gerber Kawasaki Wealth & Investment Management (201,088 shares), UBS Group AG (85,457 shares), WELLS FARGO & COMPANY/MN (75,506 shares), BANK OF AMERICA CORP /DE/ (61,757 shares), LPL Financial LLC (58,718 shares), Royal Bank of Canada (54,618 shares), JPMORGAN CHASE & CO (31,778 shares), YHB Investment Advisors, Inc. (22,855 shares), and CreativeOne Wealth, LLC (20,930 shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.